enbrel 25 mg/1 bočica prašak i otapalo za otopinu za injekciju
pfizer bh d.o.o. - etanercept - prašak i otapalo za otopinu za injekciju - 25 mg/1 bočica - 1 bočica sa praškom za otopinu za injekciju sadrži: 25 mg etanercepta; 1 šprica sa otapalom sadrži: 1 ml vode za injekcije
vaxchora
bavarian nordic a/s - холерный вибрион, soj i cvd 103-hgr na, živjeti - kolera - cjepiva - vaxchora is indicated for active immunisation against disease caused by vibrio cholerae serogroup o1 in adults and children aged 2 years and older. cjepivo bi trebao biti korišten u skladu sa službenim preporukama.
benefix
pfizer europe ma eeig - nonacog alfa - hemofilija b - antihemorrhagics - liječenje i profilaksu krvarenja kod bolesnika s hemofilijom b (nedostatak prirođenih faktora ix).
fluenz
medimmune llc - Реассортанта virusa gripe (live аттенуированная) sljedećih sojeva:a/california/7/2009 pdm09 (Н1n1)kao soj a/victoria/361/2011 (Н3n2), kao što su napon, b/ma/2/2012 kao soj - influenza, human; immunization - cjepiva - profilaksa gripe kod osoba od 24 mjeseca do 18 godina starosti. korištenje fluenz mora se temeljiti na službenim preporukama.
zykalor 10 mg tablete
medochemie ltd., constatinoupoleos str. 1-10, limassol, cipar - aripiprazol - tableta - 10 mg - urbroj: svaka tableta sadrži 10 mg aripiprazola
zykalor 15 mg tablete
medochemie ltd., constatinoupoleos str. 1-10, limassol, cipar - aripiprazol - tableta - 15 mg - urbroj: svaka tableta sadrži 15 mg aripiprazola
dengvaxia
sanofi pasteur - chimeric yellow fever dengue virus serotype 1 (live, attenuated), chimeric yellow fever dengue virus serotype 2 (live, attenuated), chimeric yellow fever dengue virus serotype 3 (live, attenuated), chimeric yellow fever dengue virus serotype 4 (live, attenuated) - denga - cjepiva - dengvaxia is indicated for the prevention of dengue disease caused by dengue virus serotypes 1, 2, 3 and 4 in individuals 6 to 45 years of age with test-confirmed previous dengue infection (see sections 4. 2, 4. 4 i 4. korištenje dengvaxia moraju biti u skladu sa službenim preporukama.
kymriah
novartis europharm limited - tisagenlecleucel - precursor b-cell lymphoblastic leukemia-lymphoma; lymphoma, large b-cell, diffuse - drugi antineoplastični agensi - kymriah is indicated for the treatment of:• paediatric and young adult patients up to and including 25 years of age with b cell acute lymphoblastic leukaemia (all) that is refractory, in relapse post transplant or in second or later relapse. • adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl) after two or more lines of systemic therapy. • adult patients with relapsed or refractory follicular lymphoma (fl) after two or more lines of systemic therapy.
fosavance 70 mg/1 tableta+ 70 µg/1 tableta tableta
merck sharp & dohme bh d.o.o. - alendronska kiselina, holekalciferol - tableta - 70 mg/1 tableta+ 70 µg/1 tableta - 1 tableta sadrži: 70 mg alendronska kiselina (u obliku alendronatnatrijuma) 70 mcg (2800 i.j.) holekalciferol
zabdeno
janssen-cilag international n.v. - recombinant adenovirus type 26 (ad26) encoding the glycoprotein (gp) of the ebola virus zaire (zebov) mayinga strain - Геморрагическая groznice ebole - cjepiva - active immunization for prevention of disease caused by ebola virus (zaire ebolavirus species) in individuals ≥ 1 year of age.